Iron Deficiency Anemia Market Insight, Epidemiology, and Market Forecast Analysis Report
What is Iron Deficiency Anemia?
Iron Deficiency Anemia (IDA) is a common type of anemia in which blood lacks adequate healthy red blood cells that carries oxygen to the body’s tissues.
What are Iron Deficiency Anemia causes?
The cause of Iron Deficiency Anemia is insufficient iron without which the body cannot produce enough hemoglobin in red blood cells that enables them to carry oxygen.
How Iron Deficiency Anemia affected population?
Iron Deficiency Anemia Epidemiology
- Approximately 10 million people were iron deficient in the United States, including 5 million who had iron deficiency anemia.
- About 50% of the women and children (preschool and school-age) and ~30% of the men with iron deficiency were also anemic.
- The annual incidence rates of IDA ranged between 7.2 and 13.96 per 1000 person-years in four European countries (Italy, Belgium, Germany and Spain).
To know more, request sample pages @ Iron Deficiency Anemia Market Landscape
Iron Deficiency Anemia Market Outlook
The Iron Deficiency Anemia therapy market in the United States held the largest market share in 2019 in North America region & is expected to register a CAGR of 7.2% during the forecast period.
Even though oral Iron therapy is the first-line therapy for patients with IDA, patients in whom the gastrointestinal blood loss exceeds the intestinal ability to absorb iron may develop Iron Deficiency Anemia refractory to oral iron supplementation. This population of patients proves to be the most challenging to manage. Iron therapy may also cause severe adverse effects. So, there is an urgent demand for novel therapies that can overcome the limitation of existing therapies.
What are the present Iron Deficiency Anemia market drivers?
The rising number of Iron Deficiency Anemia patients, increasing awareness, and increasing research and development activities are some of the factors which are expected to contribute towards the Iron Deficiency Anemia market growth.
Which are the leading companies in the Iron Deficiency Anemia market?
With the increasing demand and awareness, pharmaceutical companies are working to develop several novel Iron Deficiency Anaemia drugs and launch their novel product during the forecast period [2020–2030]. The expected launch of as MPB-1514 (MegaPro Biomedical), Ferumoxytol (AMAG Pharmaceuticals), CSJ137(Novartis Pharmaceuticals) and Injectafer (American Regent) shall fuel the growth of the Iron Deficiency Anaemia market during the forecast period, i.e., 2020–2030.
Request sample pages for more information on Iron Deficiency Anemia Market Size
Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/